Proactiveinvestors recommends
Stocktube video
08/03/2013

Advanced Computer buys Computer Software for £110mln in cash

View full size
Additional Information
Market: AIM
Sector: Software & Computer Services
EPIC: ASW
1 year chart More charts
digital-look imported chart image
Deal ASW Tax Free*
*subject to change and depends on individual circumstances.
1 day chart More charts
digital-look imported chart image
Advertisement
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Advanced Computer Software Group plc
www.advancedcomputersoftware.com

Advanced Computer Software Plc comprises three main divisions: Business Solutions, Health & Care and Managed Services. Together, these divisions provide a range of software and IT services that enable public, private and third sector organisations to retain control, improve visibility and gain efficiencies through streamlined...

Read more
Full Advanced Computer Software Group plc profile here
Pdf

Advanced Computer Software buys COA Solutions for £100 mln

February 11 2010, 1:13pm Advanced Computer Software buys COA Solutions for £100 mln

Advanced Computer Software (AIM: ASW) announced the acquisition of Redac Holdings Limited, owner of software group COA Solutions, from Alchemy Partners for £100 million, which it said was immediately earnings enhancing and highly cash generative with strong recurring revenues.

The payment for COA will comprise cash and £55 million of new bank facilities - a term loan of £25 million and revolving credit of £30 million - which are committed for three and a half years and provided by HSBC (LSE: HSBA) and Royal Bank of Scotland (LSE: RBS).

Surrey-based COA Solutions provides of software and IT services to the public and private sectors. Its principal products include systems for budgeting around patient pathways, data analysis, business intelligence, compliance, accounting and billing, procurement and document management.

It has in excess of 5,000 direct and indirect customers in healthcare, public and emergency services and the private sector.

ACS said the deal significantly strengthens its position in the healthcare and public sector markets, creating opportunities for cross-selling both ACS and COA products.

“There are substantial opportunities to cross sell our existing healthcare products into new markets while many of our existing healthcare clients could benefit from management tools in the COA product suite. Furthermore, it gives us a substantial and profitable commercial arm with a blue-chip client base that we will combine with our existing commercial arm,” said chief executive of ACS Vin Murria.

COA posted revenues of £59.8 million in the full year to 31 March 2009 - of which more than 50 percent contracted recurring - , while EBITDA (earnings before interest, taxes, depreciation and amortisation) amounted to £12.3 million. The business has more than 1,600 corporate clients including Barclays (LSE: BARC), RBS (LSE: RBS), Santander LSE: BNC, NYSE: STD, Euronext: SANT), British Airways (LSE: BAY), Virgin, Trinity Mirror (LSE: TNI) and Specsavers.

Pro-forma revenues for the enlarged group to 28 February 2010 are expected to be approximately £90 million with an EBITDA of £21 million, including £50 million of contracted recurring subscription and maintenance revenue.

ACS said that it continues to trade in line with market expectations.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.